The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Urology

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.eururo.2009.09.022PMID 19765886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up.

  2010cited by this paper
• Overdiagnosis of bladder carcinoma.

  2008cited by this paper
• Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.

  2008cited by this paper
• Interobserver Variability Between Expert Urologic Pathologists for Extraprostatic Extension and Surgical Margin Status in Radical Prostatectomy Specimens

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Histologic grading of noninvasive papillary urothelial neoplasms.

  2007cited by this paper
• Comparison of 1998 WHO/ISUP and 1973 WHO Classifications for Interobserver Variability in Grading of Papillary Urothelial Neoplasms of the Bladder

  2007cited by this paper
• A CRITICAL APPRAISAL OF THE CLASSIFICATION OF UROTHELIAL TUMOURS: TIME FOR A REVIEW OF THE EVIDENCE AND A RADICAL CHANGE?

  2007cited by this paper
• Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

  2006cited by this paper
• Review pathology in a diagnostic bladder cancer trial: effect of patient risk category.

  2006cited by this paper
• Clinical Implications of the 2004 WHO Histological Classification on Non-Invasive Tumours of the Urinary Bladder

  2006cited by this paper
• World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs

  2005cited by this paper
• Web-based virtual microscopy in teaching and standardizing Gleason grading.

  2005cited by this paper
• Pathology and genetics of tumours of the urinary system and male genital organs

  2004cited by this paper
• Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder

  2003cited by this paper
• Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.

  2003cited by this paper
• Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.

  2003cited by this paper
• Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care.

  2002cited by this paper
• Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

  2001cited by this paper
• Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer

  2000cited by this paper
• Histological Typing of Urinary Bladder Tumours

  1999cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

  1998influential reference
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

  1998cited by this paper
• Factors affecting recurrence and progression in superficial bladder tumours.

  1995cited by this paper
• Biology and management of bladder cancer.

  1990cited by this paper
• Analysis of the performance of pathologists in the grading of bladder tumors.

  1983cited by this paper

• Updates in Bladder and Prostate Pathology: Diagnostic Consensus and Clinical Relevance.

  2025cites this paper
• Computational Morphological Assessment of Bladder Cancer Tissue Is Prognostic of Recurrence and Overall Survival Following Transurethral Resection

  2025cites this paper
• Grading of bladder cancer: updates, controversies and practical solutions

  2025cites this paper
• A minor high-grade component in non-invasive papillary urothelial carcinoma is not associated with a more indolent behaviour.

  2025cites this paper
• Comparison of Interobserver Variability Between Two Grading Systems Used for Urothelial Carcinoma

  2024cites this paper
• Urothelial Carcinoma With Divergent Glandular Differentiation

  2024cites this paper
• Harnblase: Tumorvorstufen und nichtinvasive Karzinome

  2024cites this paper
• International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 1

  2023cites this paper
• Recent Advances in the Classification of Bladder Cancer – Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors

  2023cites this paper
• ABC: Artificial Intelligence for Bladder Cancer grading system

  2022cites this paper
• The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes.

  2022cites this paper
• Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy

  2021cites this paper
• Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.

  2021influential citation
• Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder

  2021cites this paper
• International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma.

  2021cites this paper
• Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP)

  2020cites this paper
• Automated detection and grading of non-muscle invasive urothelial cell carcinoma of the bladder.

  2020cites this paper
• A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer

  2019cites this paper
• Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?

  2019cites this paper
• Potential Roles for Spectroscopic Coherent Raman Imaging for Histopathology and Biomedicine

  2019cites this paper
• Early-Invasive Urothelial Bladder Carcinoma and Instillation Treatment of Non-muscle-Invasive Bladder Cancer

  2018cites this paper
• Prediction models for progression of non‐muscle‐invasive bladder cancer: A review

  2018cites this paper
• The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non‐muscle‐invasive bladder cancer

  2018cites this paper
• The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer.

  2018cites this paper
• Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".

  2018cites this paper
• Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non–muscle‐invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors

  2018cites this paper
• NOS3 895G>T and CBR3 730G>A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP

  2018cites this paper
• Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies

  2018cites this paper
• Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer

  2017cites this paper
• Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.

  2017cites this paper
• Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC)

  2017cites this paper
• Histological coherent Raman imaging: a prognostic review.

  2017cites this paper
• Prognostic and Predictive Factors in Bladder Cancer

  2016cites this paper
• Urothelkarzinom der Harnblase: Klassifikation

  2016cites this paper
• Non-muscle-invasive Bladder Cancer ( TaT 1 and CIS ) EAU Guidelines on

  2016cites this paper
• Molecular imaging with CARS micro-spectroscopy.

  2016cites this paper
• Low-Grade Urothelial Neoplasia (LGUN)

  2016cites this paper
• Molecular markers in development, diagnosis and progression of nonmuscle invasive bladder cancer

  2015cites this paper
• Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens.

  2015cites this paper
• Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients

  2015cites this paper
• Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder

  2015cites this paper
• Blaaskankerpathologie: van cystoscoop naar microscoop

  2015cites this paper
• Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer

  2015cites this paper
• Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma.

  2015cites this paper
• Impact of 2004 ISUP/WHO classification on bladder cancer grading

  2015cites this paper
• Cancer Stage at Diagnosis in HIV-infected People and Transplant Recipients

  2015cites this paper
• Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications

  2015cites this paper
• Clinical Scenario: Low-Grade T1 Tumor

  2015cites this paper
• Prognostication and Risk Assessment

  2015cites this paper
• Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS)

  2014cites this paper
• Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder

  2014cites this paper
• Molecular subtyping of bladder cancer using Kohonen self-organizing maps

  2014cites this paper
• New intravesical treatment modalities for non-muscle invasive bladder cancer

  2014cites this paper
• Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder

  2014cites this paper
• Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice.

  2014cites this paper
• Microarray gene expression profiling and analysis of bladder cancer supports the sub‐classification of T1 tumours into T1a and T1b stages

  2014cites this paper
• Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.

  2013cites this paper
• Interobserver Agreement of Confocal Laser Endomicroscopy for Bladder Cancer

  2013cites this paper
• Guidelines on Non-muscle invasive Bladder Cancer

  2013cites this paper
• Tumors of the Urinary Bladder

  2013cites this paper
• EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

  2013cites this paper
• EORTC risk tables – their usefulness in the assessment of recurrence and progression risk in non–muscle–invasive bladder cancer in Polish patients

  2013cites this paper
• Bladder cancer: Validity of the 2004 system for grading Ta bladder cancer

  2012cites this paper
• Inherent Grading Characteristics of Individual Pathologists Contribute to Clinically and Prognostically Relevant Interobserver Discordance Concerning Broders' Grading of Penile Squamous Cell Carcinomas

  2012cites this paper
• Association of Tissue Promoter Methylation Levels of APC, RASSF1A, CYP26A1, and TBX15 with Prostate Cancer Progression

  2012cites this paper
• Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.

  2012cites this paper
• The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle-Invasive Bladder Cancer

  2012cites this paper
• Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.

  2012cites this paper
• Histologic grading of urothelial carcinoma: a reappraisal.

  2012cites this paper
• Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility

  2011cites this paper
• Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors.

  2011cites this paper
• Contemporary management of low-risk bladder cancer

  2011cites this paper
• Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test.

  2011cites this paper
• Lack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors

  2011cites this paper
• Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer.

  2010cites this paper
• Staging and Staging Errors in Bladder Cancer

  2010cites this paper
• Die Pathologie

  year unknowncites this paper